Minimally invasive surgery with a tube-free surgical field for Tetralogy of Fallot repair: A single-center experience

Clinical Data Collection

This study retrospectively evaluated 105 patients with ToF from a single institution who underwent MIS for ToF between 2013 and 2017. The preoperative cardiac diagnosis and the size of the pulmonary arteries (PAs) were determined by transthoracic echocardiography for all patients. Further investigation, such as angiography of the femoral artery and vein, was performed as indicated. Associated anomalies were reported. No patient had received a palliative shunt prior to ToF repair. The institutional ethics committee approved the study (RE2012-16). Written informed consent was obtained from the parents or guardians.

Study Variables

In addition to baseline patient characteristics, recorded intraoperative variables included the duration of the surgical procedure, CPB, cross-clamping, and femoral artery and vein cannulation, as well as anesthetic methods, regional cerebral oxygen saturation, colloid osmotic pressure, and lactic acid levels. The outcome data were chest drainage volume, length of stays in the intensive care unit (ICU) and in the hospital, duration of mechanical ventilation, additional interventions, and drug regimens in the ICU. Other adverse events, such as death and surgical complications, were recorded if they occurred.

Continuous variables were presented in the form of mean ± standard deviation. Discrete variables were reported as their frequencies and percentage of occurrences.

Operative Procedure

The incision sites for the proposed MIS technique, as illustrated in Figure 1 (a), were summarized as follows:

• Download figure
• Open in new tab

FIGURE 1.

Artist depiction of (a) operative incisions in overall view for the proposed minimally invasive surgery, (b) incision ➀D, (c) the oval retractor for incision ➀D, (d) femoral cannulation via incision ➁, (e) left atrial appendage cannulation via incision ➂, and (f) clamping aorta and injecting cardioplegia via incision ➃.

• Incision ➀: the main incision for the surgical field; the upper border of the 3rd intercostal space between the left edge of the sternum and the midclavicular line, 3 cm in size for most patients (3-5 cm for older patients, i.e., 3 patients in this cohort were older than 10 years).

• Incision ➁: ∼1 cm above the inguinal ligament, 3 cm in size, used for femoral artery and vein access.

• Incision ➂: left 7^th intercostal space in the midaxillary line, 1 cm in size, used for left atrial appendage (LAA) drainage tubing and postoperative chest tubing.

• Incision ➃: right 2nd intercostal space close to the sternum edge, 1 cm in size, used for aortic occlusion clamp or superior vena cava cannulation.

The following section elaborates on the rationales and functions of these incisions.

Cardiopulmonary Bypass Protocol

Incision ➀ is the main surgical field, which is a horizontal incision made by dissecting the pectoralis major muscle, along with its muscle bundle, and by incising the intercostal muscle as depicted in Figure 1 (b). During this step, special care is taken to prevent injury to the rib periosteum and mammary arteries. An oval retractor is then placed, as shown in Figure 1 (c).

The establishment of CPB requires incisions ➀, ➁, ➂, and ➃. In general, for patients older than 1 year of age, CPB is usually established by the femoral artery porous cannula (BIO-MEDICUS, Medtronic, Minneapolis, MN, USA) and a bipolar femoral vein cannula via the incision ➁, as shown in Figure 1 (d). Transesophageal echocardiography is used to facilitate placement of the bipolar vein cannula at the confluence of the persistent left superior vena cava and innominate vein. For the remaining patients (less than 1 year old), angiography is done preoperatively to determine the sizes of the femoral artery and vein, thereby confirming femoral catheterization feasibility. Access for patients with small or tortuous vessels is performed via incision ➃. The LAA tube is inserted into the LAA via incision ➂ and fixed with a 7-0 silk suture, as shown in Figure 1(e).

Then, CPB perfusion is initiated with a flow rate of 80-100 ml/kg-min at a pressure of 60-80 mmHg to achieve mild hypothermia at a nasopharyngeal temperature of 28-30°C. Vacuum-assisted venous drainage was applied with a negative pressure from -30 to -10 mmHg to assist in drawing blood from the femoral veins. The ascending aorta is clamped via incision ➃, right after the introduction3;, as shown in Figure 1 (f).

After total collapse of the patient’s heart, both the inferior vena cava (IVC) and SVC are snugged by using a Lark’s head knot or a surgeon’s knot with 7-0 silk suture, as shown in Figure 2. Particular attention is paid to ligating the IVC, because accessing the IVC during this step is challenging. It is imperative that the peripheral tissues surrounding the patient’s IVC are completely immobilized to ensure better access. Finally, innovative forceps are used to complete the ligation, as illustrated in Figure 2 (b).

• Download figure
• Open in new tab

FIGURE 2.

Artist depiction of (a) the ligation of the superior vena cava (SVC) by placing a vessel snare, (b) the ligation of the inferior vena cava (IVC) by placing a vessel snare, and (c) the procedure of repairing the ventricular septal defect (VSD) and reconstructing the right ventricular outflow tract (RVOT).

It should also be noted that prior to IVC and SVC ligation, the patient’s heart is perfused with autologous blood (10-15 ml/kg), with a potassium concentration of 26 mmol/L, a temperature of 30-32°C, and a hematocrit of 15%. Following ligation, the heart is recurrently perfused with oxygenated blood (10 ml/kg) with a potassium concentration of 9 mmol/L, a temperature of 28°C, and a hematocrit of 20%, at an interval of 15 to 20 minutes. Alternatively, it is also common practice to continuously perfuse the heart with histidine-tryptophan-ketoglutarate solution throughout the procedure. This commercial solution allows the surgical field to be ensanguined, but it may be a challenge to withdraw the solution from the femoral vein due to its low density.

Intracardiac Procedure

The intracardiac procedure is similar to those for conventional heart operations for ToF. This section summarizes the key steps in our procedure. After the thymus is removed, the pericardium is opened 2 cm superior to the phrenic nerve. Great care should be taken to avoid harming the phrenic nerve in this step. Although the majority of the pericardium is suspended, a small portion might be resected and fixed with glutaraldehyde for later RVOT reconstruction, if necessary. Tissues that are disposed to RVOT stenosis, including hypertrophic muscle tissues on the crista supraventricularis, septal and parietal band, or any other ventricular wall, should be resected. The right ventricle is opened via a longitudinal incision. The ventricular septal defect closure is performed using a 0.4-mm-thick Gore-Tex patch (W. L. Gore Inc., Newark, DE, USA) and interrupted 4-0 or 5-0 mattress sutures buttressed with artificial blood vessels (1-2 mm). The RVOT was reconstructed with the autologous pericardium, as depicted in Figure 2 (c). If present, the patent foramen ovale or atrial septal defect should be closed via either the tricuspid valve or the atrium, depending on the surgeon’s preference. Once the repair is completed, the heart is de-aired, aided by negative pressure via the cardioplegia perfusion needle that remains at the aortic root. The aortic cross-clamp is then removed and is followed by sinus rhythm recovery. When the heart regains good contractility, the patient is weaned off bypass. At the conclusion of the procedure, incision ➀ was closed by intradermal running sutures after the intercostal nerve is blocked with lidocaine. The chest drainage tube is inserted through incision ➂. Specialized instruments designed to facilitate the completion of the proposed MIS procedure are shown in Figure 3. These instruments are now commercially available.

• Download figure
• Open in new tab

FIGURE 3.

Specialized instruments developed to perform the proposed minimally invasive surgical procedure.

Patient Cohort

Table 1 summarizes baseline demographic and clinical data for all patients. Though most patients at baseline were classified as New York Heart Association functional class II, all patients were discharged as New York Heart Association functional class I. No events were found for bleeding, reoperation, conversion to open sternotomy, or any lesions to the femoral access site. Two cases utilized alternative cannulation instead of the femoral approach because (1) an infant patient had a small femoral artery with stenosis due to vasospasm, and (2) another infant patient had IVC malformation and a slender femoral vein within a collateral network.

Table 2 compared the patients’ laboratory data before and after the MIS procedure. The postoperative data indicated that all patients achieved favorable surgical outcomes. The procedural data were also tabulated in Table 2. Postoperative complications were present in 14 patients (13.3%):

• Two had left phrenic nerve palsy, leading to diaphragmatic elevation.

• Three had low cardiac output syndrome.

• One suffered a cerebral hernia with subarachnoid hemorrhage and died of acute stroke.

• One developed paroxysmal supraventricular tachycardia.

• Two developed subcutaneous emphysema.

• Five had pleural effusions.

A female, toddler patient with ToF combined with persistent left SVC died. The McGoon (1.5) and Nakata (94.6 mm²/m²) indices of this patient were at the lower end of the indices of our patient cohort. Pre-, inter-, and postoperative data showed that the surgery succeeded, although the CPB time was 128 min, which was relatively high in our cohort. The patient was in the ICU for 2 days and developed a subarachnoid hemorrhage. The patient’s symptoms were treated in a timely manner until the patient died of an acute stroke. Two patients with diaphragmatic elevation were left untreated. However, the elevation diminished (returned to a normal level) after 3 and 6 months. Otherwise, all patients recovered from complications under symptomatic treatment prior to discharge, with the exception of 1 patient who died. For example, the 3 patients with low cardiac output were treated by elevating the cardiac preload and administering a positive inotropic drug. Table 3 tabulates clinical details about the patients’ time in the ICU.

Table 4 compares the key interoperative and postoperative clinical data from the current study with data from previously published studies for MIS of ToF. The comparisons show that the MIS technique used in the present study achieves acceptable outcomes.